Insights from 2023 ESGO Annual Meeting
M

ESGO 2023 Insights: "Final OS and Long-Term Safety in the ENGOT-OV16/NOVA Phase 3 Trial of Niraparib in Patients With Recurrent Ovarian Cancer"

By Insights from 2023 ESGO Annual Meeting FEATURING Mansoor Raza Mirza
By Insights from 2023 ESGO Annual Meeting FEATURING Mansoor Raza Mirza
242 views
October 11, 2023
0 Comments
Login to view comments. Click here to Login

Related Content

AUTOPLAY
27:04
Fengting Yan

Cancer Screening Molecular Tools

06:07
Insights from 2023 ESMO Annual Meeting

ESMO 2023 Summary: "Key Updates in Gynecological Cancers"

Feat. M. Raza Mirza
06:47
UCSF School of Medicine

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+…

Feat. H. Kang
06:50
Fengting Yan

Year in Review: Ovarian Cancer

11:15
Total Health

2024 Updates in Ovarian Cancer

Feat. T. Tillmanns
25:10
Yale School of Medicine

Ovarian Cancer Prevention and Early Detection - Ovarian Cancer Does …

Feat. M. Minkin, E. Ratner
17:50
AdventHealth

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

Feat. G. Sonpavde
06:23
Total Health

Recent Highlights in Ovarian Cancer

Feat. B. Slomovitz
15:14
Brian Slomovitz

Update in Vulvar and Vaginal Cancer

28:11
OncoAlert

Ovarian Cancer: Setting a New Standard of Care

Feat. M. Raza Mirza
18:16
Insights from 2024 ESGO Annual Meeting

ESGO 2024 Insights: "Antibody-Drug Conjugates in Ovarian Cancer…

Feat. J. Kurtz
14:05
Insights from 2023 ESGO Annual Meeting

ESGO 2023 Insights: "ICON8B: GCIG Phase 3 Randomised Trial Comp…

Feat. A. Clamp
23:35
Kathleen Moore

How to Select the Best Maintenance Treatment in Patients With Ovaria…

05:32
Insights from 2023 ESMO Asia Annual Meeting

LARA Trial: Preliminary Efficacy of Pembro + Lenvatinib in Recurrent…

Feat. N. Ngoi
09:42
Erin Crane

Niraparib as 1L Maintenance Treatment for Advanced Ovarian Cancer

05:09
Insights from 2024 SGO Annual Meeting

SGO 2024 Insights: "Final OS Data of Relacorilant, a Selective …

Feat. N. Colombo
10:27
Robert McBane

2023 ISTH Insights: "The EVE Trial - Extending VTE Secondary Pr…

11:37
UCLA Health

Recurrent Cervical Cancer Updates

Feat. R. Salani
08:37
Fred Hutchinson Cancer Center

Niraparib as 1L Maintenance Treatment for Advanced Ovarian Cancer: D…

Feat. K. Banda
17:06
Ovarian Cancer Midwest Focus, University of Minnesota

Novel ADCs in Ovarian Cancer: A New Treatment Modality

Feat. S. Lheureux